All stock lists
Bicara Therapeutics Inc. (NASDAQ:BCAX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
16.89-0.18 (-1.05%)
Insider Score
––Not scored
BCAX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BCAX Stock Insider Trading Activity
BCAX stock’s insider trading shows 18 sales on the open market for an estimated $4.13M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan CEO | Sell | 3,442 | $23.43 | $80.66K | 1.9% | 181,641 | Sep 8, 2026 | — | Form 4 |
| Cohlhepp Ryan CEO | Option exercise | 17,500 | $3.79 | $66.32K | 9.6% | 199,141 | Sep 8, 2026 | — | Form 4 |
| Cohlhepp Ryan CEO | Sell | 14,058 | $22.77 | $320.05K | 7.1% | 185,083 | Sep 8, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Sell | 10,000 | $27.98 | $279.75K | 2.7% | 362,152 | Aug 10, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Option exercise | 18,750 | $3.79 | $71.06K | 10.3% | 200,391 | Aug 10, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 18,750 | $27.98 | $524.53K | 9.4% | 181,641 | Aug 10, 2026 | — | Form 4 |
| Hyep Ivan CFO | Option exercise | 12,500 | $3.79 | $47.37K | 9.6% | 142,355 | Aug 10, 2026 | — | Form 4 |
| Hyep Ivan CFO | Sell | 12,500 | $27.97 | $349.59K | 8.8% | 129,855 | Aug 10, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Option exercise | 10,000 | $3.79 | $37.90K | 2.8% | 372,152 | Aug 10, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Option exercise | 10,000 | $3.79 | $37.90K | 2.8% | 372,152 | Jul 10, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Sell | 9,972 | $28.42 | $283.37K | 2.7% | 362,180 | Jul 10, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Sell | 28 | $29.68 | $831.04 | 0.0% | 362,152 | Jul 10, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 536 | $29.00 | $15.54K | 0.3% | 181,641 | Jul 9, 2026 | — | Form 4 |
| Hyep Ivan CFO | Sell | 4,413 | $29.82 | $131.62K | 3.3% | 130,685 | Jul 8, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Option exercise | 18,750 | $3.79 | $71.06K | 9.8% | 210,391 | Jul 8, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 22,833 | $28.76 | $656.65K | 10.9% | 187,558 | Jul 8, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 4,306 | $29.80 | $128.30K | 2.3% | 183,252 | Jul 8, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 1,075 | $30.35 | $32.63K | 0.6% | 182,177 | Jul 8, 2026 | — | Form 4 |
| Hyep Ivan CFO | Option exercise | 12,500 | $3.79 | $47.37K | 8.6% | 157,855 | Jul 8, 2026 | — | Form 4 |
| Hyep Ivan CFO | Sell | 22,757 | $28.60 | $650.90K | 14.4% | 135,098 | Jul 8, 2026 | — | Form 4 |
| Hyep Ivan CFO | Sell | 830 | $30.31 | $25.16K | 0.6% | 129,855 | Jul 8, 2026 | — | Form 4 |
| Hyep Ivan CFO | Option exercise | 9,200 | $3.79 | $34.87K | 6.3% | 154,555 | May 21, 2026 | — | Form 4 |
| Hyep Ivan CFO | Sell | 9,200 | $20.42 | $187.88K | 6.0% | 145,355 | May 21, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Sell | 12,022 | $19.96 | $239.98K | 3.2% | 365,130 | May 18, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Option exercise | 15,000 | $3.79 | $56.85K | 4.1% | 377,152 | May 18, 2026 | — | Form 4 |
| Mazumdar Claire CEO | Sell | 2,978 | $20.35 | $60.60K | 0.8% | 362,152 | May 18, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Sell | 8,000 | $20.29 | $162.34K | 3.9% | 196,141 | May 15, 2026 | — | Form 4 |
| Cohlhepp Ryan COO | Option exercise | 8,000 | $3.79 | $30.32K | 4.1% | 204,141 | May 15, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.